Literature DB >> 10075884

Characterization of mRNA endonucleases.

D R Schoenberg1, K S Cunningham.   

Abstract

Endonucleases are key effectors of mRNA degradation, particularly for mRNAs whose turnover rates are regulated by extracellular stimuli. The rapid clearance of mRNA degradation products in vivo and the need to selectively identify mRNA endonucleases in the presence of many other cellular ribonucleases make the study of these enzymes particularly challenging. We have successfully purified and cloned one such enzyme, termed polysomal RNase 1, or PMR-1. Presented here are protocols either developed in our laboratory or adapted from the work of others that we have used successfully in characterizing PMR-1. We first describe methods to determine whether a particular mRNA is degraded in vivo through an endonuclease-initiated mechanism, and then present approaches for developing an in vitro mRNA degradation system. Next we describe experiments one should perform to optimize reaction conditions, determine cofactor requirements for an endonuclease, map in vitro cleavage sites, and characterize endonucleolytic cleavage products. Finally we describe kinetic parameters one should evaluate in characterizing the enzymology of mRNA endonucleases, with particular concern focused on the relative selectivity of these enzymes for cleavage at preferred sites within target mRNAs. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075884     DOI: 10.1006/meth.1998.0708

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  15 in total

1.  Identification of in vivo mRNA decay intermediates corresponding to sites of in vitro cleavage by polysomal ribonuclease 1.

Authors:  M N Hanson; D R Schoenberg
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

2.  Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.

Authors:  K S Cunningham; R E Dodson; M A Nagel; D J Shapiro; D R Schoenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  An endonuclease activity similar to Xenopus PMR1 catalyzes the degradation of normal and nonsense-containing human beta-globin mRNA in erythroid cells.

Authors:  Kirsten A Bremer; Audrey Stevens; Daniel R Schoenberg
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

4.  Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  c-Src activates endonuclease-mediated mRNA decay.

Authors:  Yong Peng; Daniel R Schoenberg
Journal:  Mol Cell       Date:  2007-03-09       Impact factor: 17.970

6.  Identification of a cytoplasmic complex that adds a cap onto 5'-monophosphate RNA.

Authors:  Yuichi Otsuka; Nancy L Kedersha; Daniel R Schoenberg
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

7.  The 3' ends of human pre-snRNAs are produced by RNA polymerase II CTD-dependent RNA processing.

Authors:  Patricia Uguen; Shona Murphy
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

8.  RU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA.

Authors:  Stacey Hull; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization.

Authors:  H Tourrière; I E Gallouzi; K Chebli; J P Capony; J Mouaikel; P van der Geer; J Tazi
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Beta -Globin mRNA decay in erythroid cells: UG site-preferred endonucleolytic cleavage that is augmented by a premature termination codon.

Authors:  Audrey Stevens; Yang Wang; Kirsten Bremer; Jing Zhang; Robert Hoepfner; Michael Antoniou; Daniel R Schoenberg; Lynne E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.